Patients and methods
Sixty patients were studied (32 males 28 females, age range 14 to 75 yr). All were undergoing inpatient investigation for possible pancreatic disease. or for evaluation of pancreatic exocrine function after pancreatic resection. All patients had both a secretin-CCK test and a fluorescein-dilaurate test. Details of the individual patients together with the final diagnosis are shown in 'Fables 1-3. S1 ('Rt-'I'N('-l0()1 C''S'I'() KININ gastrointestinal motility or secretion were stopped five days before the test.
A 0 5 ml aliquot of urine was mixed with 4-5 ml of 0 1 mol sodium hydroxide and heated to 70°C for 10 min in a water bath. (Table 2 ) and in five patients the results were equivocal (Table 3 ). In the patients with unequivocal secretin-CCK tests (n = 55) the fluorescein-dilaurate test had a sensitivity of 100% and a negative predictive value of 100% (Table 4 ). There was a 54% false-positive rate.
The overall relation between the results of the fluorescein-dilaurate test and maximal bicarbonate secretion is depicted in the Figure. 
Discussion
The fluorescein dilaurate test is easy to perform, acceptable to patients, has a high sensitivity and negative predictive value, and is therefore likely to be a useful screening test for detecting pancreatic exocrine insufficiency. It seems, on the basis of our results, that a normal fluorescein-dilaurate test makes it highly unlikely that patient has pancreatic insufficiency. In this study approximately half of the patients with normal bicarbonate and enzyme responses to secretin and CCK had normal Each point denotes resultfrom one patient. The three different types ofsymbol depict patients sw'ith respective bicarbonate secretory capacity (see key). The horizontal line shows the lower limit ofnormalfluorescein excretion.
The hatched sertical column shows range (f equivocal bicarbonate outputs. 
fluorescein dilaurate tests and therefore may have been spared intubation. However, in view of the 54% false-positive rate, it seems that the high sensitivity of the test has been achieved only at the expense of low specificity.
We have used the maximal bicarbonate response to secretin and CCK as the diagnostic criterion for pancreatic exocrine insufficiency, since this criterion provides the best discriminant between patients with and without pancreatic disease.2 The use of the maximal enzyme response is less satisfactory, whichever enzyme is used, because there is a considerable overlap in enzyme outputs between patients with and without pancreatic disease.
The fluorescein dilaurate test is a test of digestive capacity and is, therefore, dependent on a number of non-pancreatic factors which, if altered, can affect the validity of the test. For example, gastric acid hypersecretion, especially if there is rapid gastric emptying, may flood the duodenum with acid and render pancreatic enzymes inactive, thus giving rise to false-positive results. Since enzymic hydrolysis of fat requires the presence of conjugated bile salts, digestion of the lauryl ester may be impaired in diseases which lower bile-salt concentrations in duodenal contents. In diffuse small intestinal disease, or extensive resection or bypass as a result of disease or surgery, there may be impaired release of endogenous secretin and cholecystokinin with consequently impaired stimulation of pancreatic secretion of enzymes. These factors may have contributed to the large number of patients with false-positive tests five (20%) of whom had small intestinal disease and three (15%) had rapid intestinal transit. Eight of the nine patients with hepatobiliary disease who were studied also had falsepositive tests.
The converse situation -that is, the hydrolysis of the fluorescein dilaurate in the absence of pancreatic aryl esterase, could theoretically give rise to false-negative results. We have not observed any false-negative results with the fluorescein dilaurate test, but we cannot concur with a previous assertion that fluorescein dilaurate is hydrolysed only in the presence of pancreatic aryl esterase since two of our patients (Table 2, cases 9 and 10) who had no enzymic activity in their pancreatic juice achieved excretion ratios of 23 and 24-7 respectively The mechanism for the hydrolysis of the ester in the absence of pancreatic enzymes has not yet been defined.
Previous reports 5.6 have attested the value of the fluorescein dilaurate test, with the test giving the correct diagnosis in 93% and a false-negative rate of 0 1%. The latter studies evaluated the fluorescein-dilaurate test in preselected groups comprising especially patients with known pancreatic disease (often with gross exocrine insufficiency) so that a potentially excessively favourable assessment of diagnostic value was presented. Our study was prospective and in addition to confirming the earlier reports, gives a more accurate assessment of the value of the fluorescein-dilaurate test in clinical practice.
We conclude that the fluorescein-dilaurate test is a useful screening test for pancreatic exocrine insufficiency since its high sensitivity ensures that patients with pancreatic insufficiency are likely to be detected by an abnormal test. The negative predictive value of 100% means that in patients with a normal test it is usually unnecessary to perform a secretin-CCK test.
